Home > Healthcare > Drug Device Combination > Drug Filled Devices > Ureteral Stents Market

Ureteral Stents Market Size

  • Report ID: GMI8522
  • Published Date: Mar 2024
  • Report Format: PDF

Ureteral Stents Market Size

Ureteral Stents Market size was valued at around USD 470.6 million in 2023 and is expected to reach around USD 792.2 million by 2032 at a CAGR of 6% during the forecast period. The market is expected to experience growth driven by the increasing prevalence of urological disorders coupled with the rising demand for minimally invasive procedures.

 

Ureteral stents are thin, flexible tubes made of medical-grade materials, designed for temporary placement within the ureters. These stents are used in medical procedures to alleviate obstruction or promote healing by providing a conduit for the passage of urine. A major factor contributing to the growing demand for ureteral stents is the rising incidence of kidney stone cases.

 

For instance, according to a study published by Science Direct, in 2022, Urolithiasis was one of the most common urologic diseases worldwide, with an estimated prevalence ranging from 1% to 13% in different regions across the globe. The steady increase in the prevalence of kidney stones globally is attributed to dietary habits, sedentary lifestyles, and inadequate hydration. As kidney stones obstruct the flow of urine from the kidneys to the bladder, ureteral stents play a pivotal role in relieving this obstruction and preventing complications such as hydronephrosis and renal damage.
 

Moreover, minimally invasive surgeries, such as endoscopic and laparoscopic procedures, are becoming more prevalent for treating urological disorders. Ureteral stents are often employed postoperatively to facilitate recovery, reduce complications, and enhance patient comfort. The evolution of these advanced techniques has led to a higher demand for these minimally invasive surgical instrument as an integral component of modern urological care, driving the market's growth.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ureteral stents industry was worth USD 470.6 million in revenue in 2023 and is expected to expand at 6% CAGR from 2024-2032 attributed to the increasing prevalence of urological disorders coupled with the rising need for minimally invasive procedures.

The double pigtail segment accounted for USD 177.8 million in revenue in 2023 and is estimated to record substantial growth through 2032 owing to the unique design innovation of ureteral stents, contributing to their widespread use and acceptance in urological interventions.

North America ureteral stents market generated USD 190.6 million in revenue in 2023 and is set to exhibit robust growth during 2024-2032 driven by the significant prevalence of urological disorders, including conditions, such as kidney stones, UTIs, and bladder-related issues.

Some of the major companies operating in the ureteral stents industry are Allium Medical, B.Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast, Cook Medical, Olympus Corporation, Pnn Medical A/S, Teleflex Inc., and Uromed.

Ureteral Stents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 306
  • Countries covered: 22
  • Pages: 180
 Download Free Sample